| Title | In Vitro Identification and In Vivo Metabolic Profiling of Chemical Constituents in Moringa oleifera Seeds |
|---|---|
| Description | This study pioneered the application of UPLC-Q-Exactive Orbitrap-MS to characterize MOS-derived compounds in vitro and in vivo, concurrently elucidating major constituents' fragmentation pathways via mass spectrometry. In vitro, 81 chemical components of MOS were preliminarily characterized. 38 blood-borne components, comprising 11 prototypes and 27 metabolites, were identified in serum samples from MOS-treated rats. |
| Organism | mixed sample |
| Data Type | Other Type of Metabolome Data |
| Data Accessibility | Open-access |
| BioProject | PRJCA043577 |
| Release Date | 2025-07-23 |
| Submitter | Hao Wang (wh990273520@163.com) |
| Organization | Shenyang pharmaceutical university |
| Submission Date | 2025-07-22 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX011128-01 | MOSserumNEG | 1 | Other Type of Metabolome Data | 156.83 MB | zip | |
| OMIX011128-02 | MOSserumPOS | 1 | Other Type of Metabolome Data | 139.06 MB | zip | |
| OMIX011128-03 | blankserumNEG | 1 | Other Type of Metabolome Data | 160 MB | zip | |
| OMIX011128-04 | BlankserumPOS | 1 | Other Type of Metabolome Data | 136.73 MB | zip | |
| OMIX011128-05 | MIXEDPOS | 1 | Other Type of Metabolome Data | 130.55 MB | zip | |
| OMIX011128-06 | MOSPOS | 1 | Other Type of Metabolome Data | 182.31 MB | zip | |
| OMIX011128-07 | MIXEDNEG | 1 | Other Type of Metabolome Data | 151.86 MB | zip | |
| OMIX011128-08 | MOSNEG | 1 | Other Type of Metabolome Data | 186.44 MB | zip |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer | Signal Transduction and Targeted Therapy | 2025-09 | OMIX011128 | Deposit |